Cyclosporin for refractory ulcerative colitis

Gut

Volumn 52, Issue 2, 2003, Pages 172-173

  Loftus, C G ^a   Loftus Jr , E V ^a   Sandborn, W J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; MERCAPTOPURINE; METHYLPREDNISOLONE; PREDNISOLONE;

CLINICAL TRIAL; DEATH; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ENTERITIS; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; INFECTION; KIDNEY FAILURE; MAINTENANCE THERAPY; PARESTHESIA; PRIORITY JOURNAL; REMISSION; SEIZURE; SHORT SURVEY; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; AZATHIOPRINE; COLITIS, ULCERATIVE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0037301721     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.2.172     Document Type: Short Survey

References (9)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis: part 1: short-term prognosis. Gut 1963;4:300-8.
2. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
3. D'Heans G, Lemmens L, Hiele M, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.
4. Svanoni F, Bonassi U, Bagnolo F, et al. Effectiveness of cyclosporine A (CsA) in the treatment of active refratory ulcerative colitis (UC). Gastroenterology 1998;114:A1096.
5. Van Assche G, D'Haens G, Noman M, et al. Randomized double blind comparison of 4 mg/kg versus 2 mg/kg IV cyclosporine in severe ulcerative colitis. Gastroenterology 2002;122:A668.
6. Holt DW Mueller EA Kovarik JM et al. The pharmacokinetics of Sandimmune Neoral: a new oral formulation of cyclosporine. Transpl Proc 1994;26:2935-9.
7. Sandborn WJ. Cyclosporine in ulcerative colitis: state of the art. Acta Gastroenterol Belg 2001;64:201-4.
8. Sternthal M, George J, Kornbluth A, et al. Toxicity associated with the use of cyclosporine in patients with inflammatory bowel disease (IBD). Gastroenterology 1996;110:A1019.
9. De Groen PC, Aksamit AJ Rakela J, et al. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987;317:861-6.